Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of the Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Patients With Prostate Cancer

NCT04389918 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT04389918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04389918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of the Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Patients With Prostate Cancer
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
October 26, 2020
Completion date
February 26, 2024
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer